Vect-Horus Enters a CNS-Focused Research Collaboration with OliX Pharmaceuticals
Partnership launched under MTEA to evaluate the potential of Vect-Horus technology to deliver siRNAs into the CNS Assessment of BBB shuttle-siRNA compatibility, CNS delivery efficiency, and biodistribution Collaboration underscores Vect-Horus' leadership in blood-brain barrier technology CNS as the next growth engine: Accelerating OliX 2.0 strategy MARSEILLE, France, and SEOUL, South Korea, Feb. 3, 2026 — […]